Treatment of diabetic rats with INI moderately reduced hyperglycemia without causing hypoglycemic episodes, attenuated hyperphagia, and in the case of T2DM and diet-induced MS, INI increased tissue sensitivity to insulin and leptin and normalized glucose tolerance [207,210,302]. This evidence concerns the gene INS and Hyperglycemia.